abs383.txt	background		risk	stratification	of	newly	diagnosed	patients	with	mantle	celllymphoma	(mcl)	primarily	is	based	on	the	mcl	international	prognostic	index(mipi)	and	ki-67	proliferative	index	single-center	studies	have	reportedinferior	outcomes	in	a	complex	karyotype	(ck)	but	this	remains	anarea	controversy	methods	authors	retrospectively	reviewed	483	from	5	academiccenters	united	states	described	effect	ck	survivaloutcomes	individuals	results	was	found	to	be	associated	inferior	overall	survival	(os)	(4	5vs	11	6	years	p<	01)	progression-free	(pfs)	(1	9	vs	4	who	underwent	high-intensity	induction	followed	by	autologousstem	cell	transplantation	(asct)	first	remission	withpoor	os	(5	1	p	=	04)	pfs	(3	7	8	amongpatients	had	no	3	8years	77)	nor	(2	46)	similarly	asct	firstremission	did	not	improve	2	12)	0years	27)	multivariable	analyses	mipi	only	foundto	predictive	(hazard	ratio	[hr]	98	95%	confidence	interval	[95%ci]	12-3	49	[p	02])	whereas	both	(hr	91	ci	17-3	12	01])	>30%	86	06-3	28	03])	were	withinferior	analysis	identify	any	specific	cytogeneticabnormalities	conclusions	appears	independently	inpatients	regardless	intensity	therapy	receipt	ofasct	cytogenetics	should	incorporated	into	workup	new	diagnosis	ofmcl	novel	therapeutic	approaches	investigated	for	cancer	2018	124	2306-15	Â©	american	society
